Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 16

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 16
---
ance; (ii) the Arrangement,                    
 and (iii) any other actions with respect to any other transactions contemplated by this Agreement; |

| (mm) | “Contract” means any agreement, indenture, contract, lease, deed of trust, license, option, 
 instrument, arrangement, undertaking or other commitment, whether written or oral;          |

| (nn) | “Convertible Securities” means, collectively, any agreement, option, warrant, right or other                                                                                                                                                              
 security or conversion privilege issued or granted by the Company that is exercisable or convertible into, or exchangeable for, or otherwise carries the right of the holder to purchase or otherwise acquire Common Shares, including pursuant to one or 
 more multiple exercises, conversions and/or exchanges;                                                                                                                                                                                                    |

| (oo) | “Court” means the Superior Court of Québec, Commercial Division; |

| (pp) | “CVR” means a contingent value right, which shall represent the right to receive potential                             
 payments, in cash, described in, and subject to and in accordance with the terms and conditions of, the CVR Agreement; |

| (qq) | “CVR Agreement” means the contingent value rights agreement to be entered on or prior to the                           
 Effective Time into by Parent, Purchaser and the Rights Agent in substantially the form attached as Schedule F hereto; |

- 5 -

| (rr) | “Data Room” means the material contained in the Securedocs virtual data room established by 
 the Company, the index of documents of which is appended to the Disclosure Letter;          |

| (ss) | “Data Security and Privacy Requirements” means (i) all Laws relating to the privacy and                                                                                                                                                           
 security of Personal Information, or to the collection, use, or disclosure (“Processing”) of Personal Information, (ii) all Contracts between the Company and any person that are applicable to or involve the Processing of                      
 Personal Information; and (iii) all written documented Company policies and procedures relating to the Processing of Personal Information, including all published consumer-facing website and mobile application privacy policies and formalized 
 internal information security policies;                                                                                                                                                                                                           |

| (tt) | “Depositary” has the meaning specified in Section 2.15; |

| (uu) | “Disclosure Letter” means the disclosure letter executed by the Company and delivered to the 
 Purchaser on the date hereof in connection with the execution of this Agreement;             |

| (vv) | “Discontinuance” has the meaning set out in the rec